The CYTO-PV: A Large-Scale Trial Testing the Intensity of CYTOreductive Therapy to Prevent Cardiovascular Events in Patients with Polycythemia Vera

<table>Distribution of HCT values at baseline. The columns indicate HCT levels before randomization for patients allocated in the standard (black) and experimental (grey) arms.</table>

Thrombosis

fig3

Figure 3

Figure 3: The CYTO-PV: A Large-Scale Trial Testing the Intensity of CYTOreductive Therapy to Prevent Cardiovascular Events in Patients with Polycythemia Vera 

Figure 3 | The CYTO-PV: A Large-Scale Trial Testing the Intensity of CYTOreductive Therapy to Prevent Cardiovascular Events in Patients with Polycythemia Vera 